[96a5a0]: / output / allTrials / identified / NCT00002476_identified.json

Download this file

286 lines (286 with data), 14.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
{
"info": {
"nct_id": "NCT00002476",
"official_title": "Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and Neck Cancer",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Histologically confirmed squamous cell cancer of the head and neck suitable for treatment with radiotherapy T2, T3, or T4 primary lesions Any N No distant metastasis May also be anaplastic carcinoma, verrucous carcinoma, or transitional cell carcinoma (as of 1/97) No occult primaries (as of 1/97) No adenocarcinomas, lymphomas, or melanomas (as of 1/97) Synchronous head and neck tumors are eligible (tumor with the worse prognosis is entered into study) (as of 1/97) Patients receiving surgery to neck nodes only must be randomized as surgery patients (as of 1/97) Patients with tumors of the oral cavity or oropharynx may additionally elect randomization to nodal irradiation vs. no further therapy provided there is no second primary\n\nPATIENT CHARACTERISTICS: Age: 75 and under for patients electing participation in the nodal vs. no nodal irradiation portion of the study Performance status: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Fit for any protocol treatment option Willing to receive any protocol treatment option Prior malignancy allowed provided the treating clinician considers the patient cured\n\nPRIOR CONCURRENT THERAPY: Biologic therapy: No prior therapy Chemotherapy: No prior therapy Endocrine therapy: No prior therapy Radiotherapy: No prior therapy Surgery: Prior biopsy or excision allowed"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS: Histologically confirmed squamous cell cancer of the head and neck suitable for treatment with radiotherapy T2, T3, or T4 primary lesions Any N No distant metastasis May also be anaplastic carcinoma, verrucous carcinoma, or transitional cell carcinoma (as of 1/97) No occult primaries (as of 1/97) No adenocarcinomas, lymphomas, or melanomas (as of 1/97) Synchronous head and neck tumors are eligible (tumor with the worse prognosis is entered into study) (as of 1/97) Patients receiving surgery to neck nodes only must be randomized as surgery patients (as of 1/97) Patients with tumors of the oral cavity or oropharynx may additionally elect randomization to nodal irradiation vs. no further therapy provided there is no second primary",
"criterions": [
{
"exact_snippets": "Histologically confirmed squamous cell cancer of the head and neck",
"criterion": "squamous cell cancer of the head and neck",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "suitable for treatment with radiotherapy",
"criterion": "suitability for treatment with radiotherapy",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": true
}
]
},
{
"exact_snippets": "T2, T3, or T4 primary lesions",
"criterion": "primary lesion stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"T2",
"T3",
"T4"
]
}
]
},
{
"exact_snippets": "Any N",
"criterion": "nodal involvement",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "Any N"
}
]
},
{
"exact_snippets": "No distant metastasis",
"criterion": "distant metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "May also be anaplastic carcinoma, verrucous carcinoma, or transitional cell carcinoma",
"criterion": "carcinoma type",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"anaplastic carcinoma",
"verrucous carcinoma",
"transitional cell carcinoma"
]
}
]
},
{
"exact_snippets": "No occult primaries",
"criterion": "occult primaries",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No adenocarcinomas, lymphomas, or melanomas",
"criterion": "cancer type exclusion",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": [
"adenocarcinomas",
"lymphomas",
"melanomas"
]
}
]
},
{
"exact_snippets": "Synchronous head and neck tumors are eligible",
"criterion": "synchronous head and neck tumors",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"exact_snippets": "Patients receiving surgery to neck nodes only must be randomized as surgery patients",
"criterion": "surgery to neck nodes",
"requirements": [
{
"requirement_type": "randomization",
"expected_value": "surgery patients"
}
]
},
{
"exact_snippets": "Patients with tumors of the oral cavity or oropharynx may additionally elect randomization to nodal irradiation vs. no further therapy provided there is no second primary",
"criterion": "tumors of the oral cavity or oropharynx",
"requirements": [
{
"requirement_type": "randomization option",
"expected_value": "nodal irradiation vs. no further therapy"
},
{
"requirement_type": "condition",
"expected_value": "no second primary"
}
]
}
]
},
{
"line": "PATIENT CHARACTERISTICS: Age: 75 and under for patients electing participation in the nodal vs. no nodal irradiation portion of the study Performance status: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Fit for any protocol treatment option Willing to receive any protocol treatment option Prior malignancy allowed provided the treating clinician considers the patient cured",
"criterions": [
{
"exact_snippets": "Age: 75 and under",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum age",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Fit for any protocol treatment option",
"criterion": "fitness for protocol treatment",
"requirements": [
{
"requirement_type": "fitness",
"expected_value": true
}
]
},
{
"exact_snippets": "Willing to receive any protocol treatment option",
"criterion": "willingness to receive protocol treatment",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "Prior malignancy allowed provided the treating clinician considers the patient cured",
"criterion": "prior malignancy",
"requirements": [
{
"requirement_type": "cured status",
"expected_value": true
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY: Biologic therapy: No prior therapy Chemotherapy: No prior therapy Endocrine therapy: No prior therapy Radiotherapy: No prior therapy Surgery: Prior biopsy or excision allowed",
"criterions": [
{
"exact_snippets": "Biologic therapy: No prior therapy",
"criterion": "biologic therapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": false
}
]
},
{
"exact_snippets": "Chemotherapy: No prior therapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": false
}
]
},
{
"exact_snippets": "Endocrine therapy: No prior therapy",
"criterion": "endocrine therapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": false
}
]
},
{
"exact_snippets": "Radiotherapy: No prior therapy",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": false
}
]
},
{
"exact_snippets": "Surgery: Prior biopsy or excision allowed",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "prior biopsy or excision",
"expected_value": true
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}